Your search returned 7 results.

Results
	1.	Ultrathin, bioresorbable polymer sirolimus-eluting stents versus thin, durable polymer everolimus-eluting stents in patients undergoing coronary revascularisation (BIOFLOW V): a randomised trial. MedStar authors: Garcia-Garcia, Hector M Waksman, Ron PMID: 28851504 Year: 2017 Citation: Lancet. 390(10105):1843-1852, 2017 Oct 21. Institution: MedStar Heart & Vascular Institute Medline publication type: Journal Article Form of publication: Journal Article All authors: Bennett J, BIOFLOW V Investigators, Cutlip DE, Doros G, Garcia-Garcia HM, Gharib EG, Kandzari DE, Koolen JJ, Massaro JM, Mauri L, Roguin A, Waksman R DOI: https://dx.doi.org/10.1016/S0140-6736(17)32249-3 Add to cart (remove)
	2.	Ultrathin bioresorbable-polymer sirolimus-eluting stent affected lower periprocedural high-sensitivity cardiac troponin: a pilot study. MedStar authors: Garcia-Garcia, Hector M PMID: 36951735 Year: 2023 Citation: Coronary Artery Disease. 34(3):216-217, 2023 05 01. Institution: MedStar Heart & Vascular Institute Medline publication type: Journal Article Form of publication: Journal Article All authors: Dan K, Garcia-Garcia HM, Nakano T DOI: https://dx.doi.org/10.1097/MCA.0000000000001224 Add to cart (remove)
	3.	Comparison of the Ultrathin Strut, Biodegradable Polymer Sirolimus-eluting Stent With a Durable Polymer Everolimus-eluting Stent in a Chinese Population: The Randomized BIOFLOW VI Trial. MedStar authors: Garcia-Garcia, Hector M Waksman, Ron PMID: 32268942 Year: 2020 Citation: Clinical Therapeutics. 42(4):649-660.e9, 2020 04. Institution: MedStar Heart & Vascular Institute Medline publication type: Journal Article Form of publication: Journal Article All authors: BIOFLOW VI Trial Investigators, Gao R, Garcia-Garcia HM, Guan C, Han Y, Li C, Song D, Waksman R, Xu B, Xu J, Yang Y DOI: https://dx.doi.org/10.1016/j.clinthera.2020.02.014 https://dx.doi.org/10.1016/j.clinthera.2020.02.014 https://dx.doi.org/10.1016/j.clinthera.2020.02.014 https://dx.doi.org/10.1016/j.clinthera.2020.02.014 Add to cart (remove)
	4.	Efficacy and Safety of Ultrathin, Bioresorbable-Polymer Sirolimus-Eluting Stents Versus Thin, Durable-Polymer Everolimus-Eluting Stents for Coronary Revascularization of Patients With Diabetes Mellitus. MedStar authors: Kolm, Paul Lipinski, Michael J Shlofmitz, Evan Torguson, Rebecca Waksman, Ron PMID: 31353004 Year: 2019 Citation: American Journal of Cardiology. 124(7):1020-1026, 2019 10 01. Institution: MedStar Heart & Vascular Institute Medline publication type: Journal Article Form of publication: Journal Article All authors: Kandzari D, Kolm P, Koolen JJ, Lipinski MJ, Saito S, Shlofmitz E, Torguson R, Waksman R, Windecker S DOI: https://dx.doi.org/10.1016/j.amjcard.2019.06.021 Add to cart (remove)
	5.	Ultrathin Bioresorbable Polymer Sirolimus-Eluting Stents Versus Durable Polymer Everolimus-Eluting Stents: BIOFLOW V Final 5-Year Outcomes. MedStar authors: Garcia-Garcia, Hector M Waksman, Ron PMID: 36137689 Year: 2022 Citation: Jacc: Cardiovascular Interventions. 15(18):1852-1860, 2022 Sep 26. Institution: MedStar Heart & Vascular Institute Medline publication type: Journal Article Multicenter Study Randomized Controlled Trial Form of publication: Journal Article All authors: Bennett J, BIOFLOW V Investigators, Cutlip DE, Doros G, Garcia-Garcia HM, Gharib EG, Kandzari DE, Koolen JJ, Roguin A, Waksman R DOI: https://dx.doi.org/10.1016/j.jcin.2022.07.027 Add to cart (remove)
	6.	Comparison of a novel biodegradable polymer sirolimus-eluting stent with a durable polymer everolimus-eluting stent: results of the randomized BIOFLOW-II trial. MedStar authors: Waksman, Ron PMID: 25634905 Year: 2015 Citation: Circulation: Cardiovascular Interventions. 8(2):e001441, 2015 Feb. Institution: MedStar Heart & Vascular Institute Form of publication: Journal Article All authors: Barragan P, Bilger J, Cook S, Erne P, Goicolea J, Haude M, Juni P, Lefevre T, Merkely B, Neumann FJ, Piot C, Richardt G, Sabate M, Schneider H, Slagboom T, Stangl K, Waksman R, Windecker S, Witzenbichler B, Zaugg S DOI: http://dx.doi.org/10.1161/CIRCINTERVENTIONS.114.001441 Add to cart (remove)
	7.	Six-month IVUS and two-year clinical outcomes in the EVOLVE FHU trial: a randomised evaluation of a novel bioabsorbable polymer-coated, everolimus-eluting stent. MedStar authors: Weissman, Neil J PMID: 23872647 Year: 2013 Citation: Eurointervention. 9(3):308-15, 2013 Jul. Institution: MedStar Heart & Vascular Institute Medline publication type: Comparative Study Journal Article Multicenter Study Randomized Controlled Trial Research Support, Non-U.S. Gov't Form of publication: Journal Article All authors: Allocco DJ, Banning A, Barragan P, Dawkins KD, Kelbaek H, Kubica J, Masotti M, Meredith IT, Scott D, Sjogren I, Stables RH, Thuesen L, Valdes Chavarri M, Verheye S, Walters DL, Weissman NJ, West NE, Whitbourn R DOI: http://dx.doi.org/10.4244/EIJV9I3A52 Add to cart (remove)

Powered by Koha